Latest Sodium valproate Stories
50 years after valproate was first discovered, research published today in the journal Neurobiology of Disease, reports how the drug works to block seizure progression.
Throughout June and August 2013, investors and health plans are going after Depakote manufacturer Abbott Laboratories with a lawsuit regarding its marketing practices.
The anti-seizure drug valproate has been shown to be extremely effective, but a new study has found that it increases the risk of pregnant women giving birth to a child with spina bifida or hypospadias when taken in higher doses.
In response to the FDA’s Drug Safety Communications statement on May 6, 2013, Connecticut law firm Trantolo & Trantolo is accepting Depakote-related claims. Hartford,
The US Food and Drug Administration is warning women who are of childbearing age not to use several varieties of migraine medicine which could decrease the intelligence of their babies if taken while pregnant.
Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring.
According to court documents, on August 3rd, 2012, lead plaintiff Nathanael Rymsza and 6 others filed a lawsuit in St. Clair County Circuit Court (case no.
The law firm of Atkins & Markoff, a team of Oklahoma defective drug attorneys, hereby announces that the firm is reviewing claims free of charge regarding Depakote birth defects along with a full Depakote resource at http://www.atkinsandmarkoff.com.
Anticonvulsant medications such as Depakote are being found to possibly cause birth defects according to recent studies.